Treatment of anthrax infection with combination of ciprofloxacin and antibodies to protective antigen ofBacillus anthracis
Open Access
- 1 January 2004
- journal article
- Published by Oxford University Press (OUP) in FEMS Immunology & Medical Microbiology
- Vol. 40 (1) , 71-74
- https://doi.org/10.1016/s0928-8244(03)00302-x
Abstract
Currently there is no effective treatment for inhalational anthrax beyond administration of antibiotics shortly after exposure. There is need for newKeywords
This publication has 14 references indexed in Scilit:
- In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibodyJournal of Medical Microbiology, 2002
- A Recombinant Carboxy-Terminal Domain of the Protective Antigen of Bacillus anthracis Protects Mice against Anthrax InfectionInfection and Immunity, 2002
- Efficiency of Protection of Guinea Pigs against Infection with Bacillus anthracis Spores by Passive ImmunizationInfection and Immunity, 2002
- Prophylactic treatment of gram‐positive and gram‐negative abdominal implant infections using locally delivered polyclonal antibodiesJournal of Biomedical Materials Research, 2002
- Locally delivered polyclonal antibodies potentiate intravenous antibiotic efficacy against gram-negative infections.Pharmaceutical Research, 2002
- Passive transfer of protection against Bacillus anthracis infection in a murine modelVaccine, 2001
- Efficacy of Locally Delivered Polyclonal Immunoglobulin against Pseudomonas aeruginosa Peritonitis in a Murine ModelAntimicrobial Agents and Chemotherapy, 1999
- Postexposure Prophylaxis against Experimental Inhalation AnthraxThe Journal of Infectious Diseases, 1993
- Prophylaxe gramnegativer und grampositiver Infektionen mit drei intravenösen Immunglobulin-Präparaten und Therapie der experimentellen polymikrobiellen Verbrennungssepsis mit intravenösem Pseudomonas-Immunglobulin G und Ciprofloxacin im TiermodellInfection, 1987
- Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosaThe American Journal of Medicine, 1984